Notch3 regulates ferroptosis via ROS‐induced lipid peroxidation in NSCLC cells

Ferroptosis is type of programmed cell death, which is known to be involved in certain cancers. Notch3 signaling is reported to be involved in the tumorigenesis of non‐small‐cell lung cancer (NSCLC) and regulates iron metabolism, lipid synthesis, and oxidative stress in some tissues. However, whether Notch3 signaling regulates ferroptosis is unclear. In this study, we found that ferroptosis inhibitors, ferrostatin‐1 and liproxstatin‐1, protected against cell death induced by Notch3 knockdown and that Notch3 knockdown initiated ferroptosis in NSCLC cells by increasing reactive oxygen species (ROS) levels, lipid peroxidation, and Fe2+ levels, accompanied by downregulation of glutathione peroxidase 4 (GPX4) and peroxiredoxin6 (PRDX6). Conversely, Notch3 intracellular domain overexpression suppressed erastin‐induced ferroptosis, which was synergistically enhanced by MJ33 in H1299 cells via a decrease in ROS levels and lipid peroxidation, accompanied by upregulation of GPX4 and PRDX6. Moreover, Notch3 knockdown decreased tumorigenesis in vivo with downregulation of GPX4 and PRDX6. In summary, here we have identified Notch3 as a potential negative regulator of ferroptosis in NSCLC.

[1]  L. Shan,et al.  Increased hemoglobin and heme in MALDI-TOF MS analysis induce ferroptosis and promote degeneration of herniated human nucleus pulposus , 2021, Molecular Medicine.

[2]  Xiaofeng Dai,et al.  Programmed cell death, redox imbalance, and cancer therapeutics , 2021, Apoptosis.

[3]  Wei Sun,et al.  Notch3 is involved in the proliferation of renal cancer cells via regulation of cell cycle progression and HIF-2α. , 2020, Oncology letters.

[4]  J. Bárcena,et al.  Knockout of PRDX6 induces mitochondrial dysfunction and cell cycle arrest at G2/M in HepG2 hepatocarcinoma cells , 2020, Redox biology.

[5]  Y. Jiao,et al.  The Role of Erastin in Ferroptosis and Its Prospects in Cancer Therapy , 2020, OncoTargets and therapy.

[6]  Shimeng Huang,et al.  SIRT3 deficiency is resistant to autophagy‐dependent ferroptosis by inhibiting the AMPK/mTOR pathway and promoting GPX4 levels , 2020, Journal of cellular physiology.

[7]  C. D. Dela Cruz,et al.  Lung Cancer 2020: Epidemiology, Etiology, and Prevention. , 2020, Clinics in chest medicine.

[8]  Yichi Xu,et al.  Overexpression and biological function of PRDX6 in human cervical cancer , 2020, Journal of Cancer.

[9]  W. Travis Lung Cancer Pathology: Current Concepts. , 2020, Clinics in chest medicine.

[10]  Hong Li,et al.  Target genes associated with lipid and glucose metabolism in non-alcoholic fatty liver disease , 2019, Lipids in Health and Disease.

[11]  T. Vanden Berghe,et al.  Targeting Ferroptosis to Iron Out Cancer. , 2019, Cancer cell.

[12]  Qiaojun He,et al.  Identification of PRDX6 as a regulator of ferroptosis , 2019, Acta Pharmacologica Sinica.

[13]  F. Fang,et al.  Extrinsic Calcitonin Gene-Related Peptide Inhibits Hyperoxia-Induced Alveolar Epithelial Type II Cells Apoptosis, Oxidative Stress, and Reactive Oxygen Species (ROS) Production by Enhancing Notch 1 and Homocysteine-Induced Endoplasmic Reticulum Protein (HERP) Expression , 2017, Medical science monitor : international medical journal of experimental and clinical research.

[14]  E. Giyazitdinova,et al.  7 T MRI reveals diffuse iron deposition in putamen and caudate nucleus in CADASIL , 2016 .

[15]  Dandan Zong,et al.  Notch signaling in lung diseases: focus on Notch1 and Notch3 , 2016, Therapeutic advances in respiratory disease.

[16]  Takaaki Ito,et al.  Evaluation of role of Notch3 signaling pathway in human lung cancer cells , 2016, Journal of Cancer Research and Clinical Oncology.

[17]  M. Cengiz,et al.  Resveratrol can prevent CCl₄-induced liver injury by inhibiting Notch signaling pathway. , 2016, Histology and histopathology.

[18]  J. Aster,et al.  The Role of Notch Receptors in Transcriptional Regulation , 2015, Journal of cellular physiology.

[19]  Takaaki Ito,et al.  Notch1 signaling controls cell proliferation, apoptosis and differentiation in lung carcinoma. , 2014, Lung cancer.

[20]  R. Yazdanparast,et al.  Modulation of Notch Signaling Pathway to Prevent H2O2/Menadione-Induced SK-N-MC Cells Death by EUK134 , 2014, Cellular and Molecular Neurobiology.

[21]  D. Y. Hwang,et al.  Loss of presenilin 2 is associated with increased iPLA2 activity and lung tumor development , 2014, Oncogene.

[22]  D. Yoon,et al.  PRDX6 promotes lung tumor progression via its GPx and iPLA2 activities. , 2014, Free radical biology & medicine.

[23]  Matthew E. Welsch,et al.  Regulation of Ferroptotic Cancer Cell Death by GPX4 , 2014, Cell.

[24]  E. Wang,et al.  The Roles of Notch3 on the Cell Proliferation and Apoptosis Induced by CHIR99021 in NSCLC Cell Lines: A Functional Link between Wnt and Notch Signaling Pathways , 2013, PloS one.

[25]  Baljit Singh,et al.  A link between premenopausal iron deficiency and breast cancer malignancy , 2013, BMC Cancer.

[26]  E. Chun,et al.  Phospholipase A2 of peroxiredoxin 6 has a critical role in tumor necrosis factor-induced apoptosis , 2011, Cell Death and Differentiation.

[27]  Raphael Kopan,et al.  The Canonical Notch Signaling Pathway: Unfolding the Activation Mechanism , 2009, Cell.

[28]  Y. Sun,et al.  Programmed cell death and cancer , 2009, Postgraduate Medical Journal.

[29]  K. Forsman-Semb,et al.  Mice with Targeted Mutation of Peroxiredoxin 6 Develop Normally but Are Susceptible to Oxidative Stress* , 2003, Journal of Biological Chemistry.

[30]  H. Imai,et al.  Lipid Peroxidation-Dependent Cell Death Regulated by GPx4 and Ferroptosis. , 2017, Current topics in microbiology and immunology.